594 related articles for article (PubMed ID: 29180076)
1. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
[TBL] [Abstract][Full Text] [Related]
2. Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy.
Hansen CR; Johansen J; Samsøe E; Andersen E; Petersen JBB; Jensen K; Andersen LJ; Sand HMB; Bertelsen AS; Grau C
Radiother Oncol; 2018 Jan; 126(1):43-47. PubMed ID: 28987748
[TBL] [Abstract][Full Text] [Related]
3. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.
Brouwer CL; Steenbakkers RJ; Bourhis J; Budach W; Grau C; Grégoire V; van Herk M; Lee A; Maingon P; Nutting C; O'Sullivan B; Porceddu SV; Rosenthal DI; Sijtsema NM; Langendijk JA
Radiother Oncol; 2015 Oct; 117(1):83-90. PubMed ID: 26277855
[TBL] [Abstract][Full Text] [Related]
4. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.
Grégoire V; Ang K; Budach W; Grau C; Hamoir M; Langendijk JA; Lee A; Le QT; Maingon P; Nutting C; O'Sullivan B; Porceddu SV; Lengele B
Radiother Oncol; 2014 Jan; 110(1):172-81. PubMed ID: 24183870
[TBL] [Abstract][Full Text] [Related]
5. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
[TBL] [Abstract][Full Text] [Related]
6. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
[No Abstract] [Full Text] [Related]
7. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
8. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
[TBL] [Abstract][Full Text] [Related]
9. [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area].
Adamietz IA; Schemmann F; Baum RP; Knecht R; Saran F; Mose S; Thilmann C; Hör G; Böttcher HD
Strahlenther Onkol; 1995 May; 171(5):278-83. PubMed ID: 7770783
[TBL] [Abstract][Full Text] [Related]
10. Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma.
Grégoire V; Grau C; Lapeyre M; Maingon P
Oral Oncol; 2018 Dec; 87():131-137. PubMed ID: 30527228
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.
Moon SH; Jung YS; Ryu JS; Choi SW; Park JY; Yun T; Lee SH; Cho KH
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):140-9. PubMed ID: 20732767
[TBL] [Abstract][Full Text] [Related]
12. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
[TBL] [Abstract][Full Text] [Related]
14. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
15. P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.
Hammond E; Berkey BA; Fu KK; Trotti A; Meredith RF; Jones CU; Byhardt R; Horwitz EM; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):683-92. PubMed ID: 14529772
[TBL] [Abstract][Full Text] [Related]
16. Proposals for the delineation of neck clinical target volume for definitive Radiation therapy in patients with oral/ oropharyngeal squamous cell cancer based on lymph node distribution.
Liu YC; Zhang X; Yang HN; Zhang L; Li D; Yang MQ; Wang NH; Wu YZ; Sui JD; Wang Y
Radiother Oncol; 2024 Jun; 195():110225. PubMed ID: 38490491
[TBL] [Abstract][Full Text] [Related]
17. Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.
Truong MT; Romesser PB; Qureshi MM; Kovalchuk N; Orlina L; Willins J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):158-64. PubMed ID: 22300574
[TBL] [Abstract][Full Text] [Related]
18. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
[TBL] [Abstract][Full Text] [Related]
20. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.
Grégoire V; Levendag P; Ang KK; Bernier J; Braaksma M; Budach V; Chao C; Coche E; Cooper JS; Cosnard G; Eisbruch A; El-Sayed S; Emami B; Grau C; Hamoir M; Lee N; Maingon P; Muller K; Reychler H
Radiother Oncol; 2003 Dec; 69(3):227-36. PubMed ID: 14644481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
